Italy· 039056039
BERINERT*1 flaconcino SC 2.000 UI + 1 flaconcino solv 4 ml + dispositivo di trasferimento con filtro + set di somministrazione
A medicinal product containing proteina del plasma umano antiangioedema, registered in Italy by CSL BEHRING GmbH, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Proteina del plasma umano antiangioedema
- Manufacturer
- CSL BEHRING GmbH
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic039056039BERINERT*1 flaconcino SC 2.000 UI + 1 flaconcino solv 4 ml + dispositivo di trasferimento con filtro + set di somministrazioneEUR 3696.9
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Proteina del plasma umano antiangioedema in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandBerinertCSL Behring GmbH
- SpainRUCONEST 2100 U POLVO PARA SOLUCION INYECTABLEPharming Group N.V.
- FranceRUCONEST 2100 U, poudre et solvant pour solution injectablePHARMING GROUP (PAYS-BAS)
- United KingdomRuconest 2,100unit powder and solvent for solution for injection vialsPharming Group N.V.
- IrelandRuconest 2100 Units powder and solvent for solution for injectionPharming Group N.V.
- IcelandRuconestPharming Group N.V.*
- NetherlandsRuconest, poeder en oplosmiddel voor oplossing voor injectiePharming Group N.V.
- PolandRuconestPharming Group N.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ruconest
- Liechtenstein · Ruconest
- Norway · Ruconest
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b6493e55-6323-4f51-a39c-a2b5a4630943 GET /v1/drugs/b6493e55-6323-4f51-a39c-a2b5a4630943?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 3696.9,
"source": "aifa",
"currency": "EUR",
"strength": "PROTEINA DEL PLASMA UMANO ANTIANGIOEDEMA 2.000U 1 UNITA' USO PARENTERALE",
"substance": "Proteina del plasma umano antiangioedema",
"equivalence_group": "MBQ",
"transparency_flag": null
}See everything about proteina del plasma umano antiangioedema.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.